Skip to main content
Sign In
 

Laurie Gaspar Publications


 

PUBLISHED ARTICLES:

 

1.         Gaspar LE, Cheung AYC, Allen HH.  Cervical carcinoma: Treatment and results and complications of extended-field irradiation.  Radiology 172:271-274, 1989.

2.         McDonald DR, Gaspar LE, Cairncross JG.  Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.  Ann Neurol 27:573-574, 1990.

3.         Gaspar LE, Schold SC, Cairncross JG.  Role of surgery for high-grade astrocytomas.  J Neurosurg 74:1027-1028, 1991.

4.         Gaspar LE, Dawson DJ, Tilley-Gulliford SA, Banerjee P.  Medulloblastoma: Long term follow-up of patients treated with an electron irradiation of the spinal field.  Radiology 180:867-870, 1991.

5.        Gaspar LE, Fisher BJ, McDonald DR, LeBer DV, Halperin EC, Schold Jr. SC, Cairncross JG.  Supratentorial malignant glioma:  Patterns of recurrence and implications for external beam local treatment.  Int J Rad Oncol Biol Phys 24 (1):55-57, 1992.

6.         Gaspar LE, Barnett R, Kocha WI, Dar AR, Ago CT, Inculet R.  High dose rate esophageal brachytherapy: Initial experience.  Endocurietherapy Hyperthermia Oncology 8:5-10, 1992.

7.         Redekop GJ, Elisevich KV, Gaspar LE, Weise KP, Drake CG.  Conventional radiation therapy of intracranial arteriovenous malformations: Long term results.  J Neurosurg 78:413-422, 1993.

8.        Fisher BJ, Gaspar LE, Noone B.  Giant pituitary adenomas: Role of radiotherapy.  Int J Rad Oncol Biol Phys 25:677-681, 1993.

9.         Gaspar LE, Fisher BJ, McDonald DR, LeBer DV, Halperin EC, Schold SC, Cairncross JG.  Malignant glioma - Timing of response to radiation therapy.  Int J Rad Oncol Biol Phys 25:877-879, 1993.

10.       Fisher BJ, Gaspar LE, Noone B.  Radiation therapy of pituitary adenoma: Delayed sequelae.  Radiology 187(3):843-846, 1993.

11.       Halperin EC, Gaspar LE, George S, Darr D, Pinnell S.  A double blind, randomized prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis.  Int J Rad Oncol Biol Phys 26:413-416, 1993.

12.       Halperin EC, Gaspar LE, Imperato J, Salter M, Herndon J, Dowling S.  An analysis of radiotherapy data from the CNS Cancer Consortium's randomized prospective trial Comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors.  Am J Clin Onc (CCT) 16 (4): 277-283, 1993.

13.       Gaspar LE, Kocha WI, Barnett R, Dar AR, Ago CT, Inculet RA.  Cancer of the esophagus: Brachytherapy and external beam radiation and chemotherapy.  Cancer Journal 6 (4):196-200, 1993.

14.       McCart JA, Casson AG, Gaspar LE, Inculet R.  Predictors of survival following surgical resection of thymoma: 30 year experience.  J Surg Onc 54:233-238, 1993.

15.       Gaspar LE, MacKenzie, IRA, Fisher BJ, Cairncross JG, McDonald DR, Kaufman JCE.  Primary cerebral fibrosarcomas - Clinicopathologic study and review of the literature.  Cancer 72:3277-81, 1993.

16.       Gaspar LE.  Radiation therapy of esophageal cancer: Improving the therapeutic ratio.  Seminars in Radiation Oncology 4 (3):192-201, 1994.

17.       Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, McDonald DR, Cairncross JG.  A prospective study of short course radiotherapy in poor prognosis glioblastoma multiforme.  Int J Rad Oncol Biol Phys 29 (4):835-839, 1994.

18.       Archibald YM, Lunn D, Ruttan LA, McDonald DR, Del Maestro RF, Barr HW, Pexman WJ, Fisher BJ, Gaspar LE, Cairncross JG.  Cognitive functioning in long-term survivors of high-grade glioma.  Neurosurgery 80:247-253, 1994.

19.       Poplin E, Khanuja PS, Kraut M, Herskovic A, Lattin P, Cummings G, Gaspar LE, Kinzie J, Steiger Z, Vaitkevicius VK.  Chemoradiotherapy of esophageal carcinoma.  Cancer 74:1217-1224, 1994.

20.       Gehman KE, Gaspar LE, Barnett R, Elliott J, Shum DT, Inculet RI.  High dose rate endovascular irradiation: Tolerance of Normal Tissues.  Endocurietherapy/Hyperthermia Oncology, 10:167-171, 1994.

21.       Maruyama Y, Fontanesi J, Porter AT, Wierzbicki J, Gaspar LETreating brain cancers.  Science 266:714-715, 1994.

22.       Fisher BJ, Gaspar LE, Stitt LW, Noone BE. Pituitary adenomas in adolescents: A biologically more aggressive disease?  Radiology 192(3):869-872, 1994.

23.       Fernandez PM, Zamorano L, Yakar D, Gaspar LE, Warmelink C.  Permanent Iodine 125 implants in the up-front treatment of malignant gliomas.  Neurosurgery, 36(3):467-473, 1995.

24.       Gaspar LE, Zamorano L, Shamsa F, Had I, Warmelink C, Garcia L, Yakar D.  Permanent Iodine-125 implant in malignant glioma. Endocurietherapy/ Hyperthermia Oncology 11:193-200, 1995.

25.       Scott CB, Nelson J., Farnan NC, Curran WJ, Murray K., Fischbach A, Gaspar LE.  Central pathology review in clinical trials for patients with malignant glioma: A report of Radiation Therapy Oncology Group 83-02.  Cancer 76:307-13, 1995.

26.       Danjoux CE, Jenkins RD, McLaughlin L, Grimard L, Gaspar LE, Dar AR, Fisher B, Whitton AC, Kraus V, Springer CD, Kotalik JF. Childhood medulloblastoma in Ontario, 1977-1987: Population-based results. Med Ped Oncol 26(1):1-9, 1996.

27.       Halperin EC, Herndon J, Schold SC, Brown M, Vick N, Cairncross JG, McDonald DR, Gaspar LE, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Palealagos N, Burger P, Bentel GC, Friedman A.  A phase III randomized rrospective trial of external beam radiotherapy, Mitomycin C, BCNU, and 6 Mercaptopurine for the treatment of adults with anaplastic glioma of the brain.  Int J Rad Onc Biol Phys 34:793-802, 1996.

28.       Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray K., Fischbach JA, Nelson J., Weinstein AS, Curran WJ.  Final report of a phase I/II trial of hyperfractionated (HF) and accelerated hyperfractionated (AHF) radiation therapy (RT) with carmustine for adults with supratentorial malignant gliomas: RTOG 83-02.  Cancer 77:1535-1543, 1996.

29.       Mintz AH, Kestle J, Rathbone MP, Gaspar LE, Hugenholtz H, Fisher B, Duncan G, Skingley P, Foster G, Levine M. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78:1470-1476, 1996.

30.       Kirby S, McDonald D, Fisher B, Gaspar LE, Cairncross G. Pre-Radiation Chemotherapy for Anaplastic Glioma. Can J Neurol Sci 23(2):123-127, 1996.

31.       Gaspar LE, Qian C, Kocha WI, Coia LR, Herskovic A, Graham M.  A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207). Int J Rad Oncol Biol Phys, 37:593-599, 1997.

32.       Gaspar LE, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastasises trials. Int J Rad Oncol Biol Phys, 37(4):745-751, 1997.

33.       Gaspar LE, Nag S, Herskovic A, Matravadi P, Speiser B. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Rad Oncol Biol Phys, 38(1):127-132, 1997.

34.       Donahue B, Scott C, Rotman M, Murray K., Nelson D, Earle JD, Fischbach JA, Gaspar LE, Curran W.  Influence of an oligodendrogliomal component on the survival of patients who have anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 83-02.  Int J Rad Oncol, Biol Phys., 38(5):911-914, 1997.

35.       Gaspar LE.  Brachytherapy in lung cancer.  J Surg Oncol 67:60-70, 1998.

36.       Zamorano L, Saenz A, Matter A, Buciuc R, Gaspar LE, Fontanesi J, Garzon A, Diaz F.  Radiosurgical treatment of meningiomas.  Radiosurgery 69:156-161, 1997.

37.       Zamorano L, Matter A, Gaspar LE, Saenz A, Buciuc R, Fontanesi J, Garzon A, Diaz F.  Radiosurgery for cerebral arteriovenous malformations.  Journal of Radiosurgery 1 (3):225-231, 1998.

38.       Komaki R, Scott C, Byhardt R, Emami B, Asbell S, Russell A, Roach M, Parliament M, Gaspar LE.  Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four Radiation Therapy Oncology Group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).  Int J Oncol Biol Phys 42(2):263-267, 1998.

39.       Cox J, Scott C, Byhardt R, Emami B, Russell A, Fu K, Parliament M, Komaki R, Gaspar LE.  Addition of chemotherapy to radiation therapy alters failure patterns by cell type within “non-small” cell carcinoma of lung (NSCCL): Analysis of Radiation Therapy Oncology Group (RTOG) trials.  Int J Rad Oncol Biol Phys 43(3):505-509, 1999.

40.       Gaspar LE, Shamsa F, Fontanesi J, Ezzell G, Yakar D, Zamorano L.  Permanent Iodine-125 implants for recurrent malignant gliomas.  Int J Rad Oncol Biol Phys. 15;43(5):977-82, 1999.

41.       Gadgeel SM, Ralalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE, Kalemkerian GP.  Lung cancer in patients <50 years of age: The experience of an academic multidisciplinary program.  Chest 115: 1232-1236, 1999.

42.       Streeter Jr. OE, Martz KL, Gaspar LE, Delrowe JD, Asbell SO, Roach III M, Salter MM.  Does race influence survival for esophageal cancer patients treated on the radiation and chemotherapy arm of RTOG 85-01.  Int J Radiat Oncol Biol Phys. 15;44 (5): 1047-52, 1999.

43.       Abdel-Wahab M, Corn B, Wolfson A, Raub W, Gaspar LE, Curran W, Bustillo P, Rubinson P Markoe A.  Prognostic factors and survival in spinal cord gliomas after radiation therapy.  Am J Clin Oncol, 22(4):344-351, 1999.

44.       Kalemkerian GP, Belzer K, Wozniak AJ, Gaspar LE, Valdivieso M, Kraut MJ. Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer. Lung Cancer, 25(3):175-82, 1999.

45.       Videtic GMM, Gaspar LE, Zamorano L, Tekyi-Mensah S, Garzon A, Levin KJ, Diaz F.  g-Knife Radiosurgery for brainstem lesions: The Wayne State University experience. J Radiosurgery,  2(3):135-139, 1999.

46.       Videtic GMM, Gaspar LE, Zamorano L, Fontanesi J, Levin K, Kupsky W, Tekyi-Mensah S.  Use of the RTOG recursive partitioning analysis to validate the benefit of Iodine-125 implants in the primary treatment of malignant gliomas.  Int J Rad Oncol Biol Phys, 45(3):687-692, 1999.

47.       Videtic GM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S.  Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.  Int J Radiat Oncol Biol Phys 1999 Oct 1; 45(3):687-692.

48.       Herskovic A, Scott C, Demas W, Gaspar LE, Trotti A.  Accelerated hyperfractionation for bronchogenic cancer - Radiation Therapy Oncology Group 9205.  J Clin Oncol, 23(2): 207-212, 2000.

49.       Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M.  A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207): Final report.  Cancer, 88 (5):988-95, 2000.

50.       Gaspar LE, Gutin PH, Rogers L, Schneider JF, Larson D, Bloomer WD, Buckley JA, Gibbs FA, Lewin AA, Loeffler JS, Malcolm AW, Medenhall WM, Schupak KD, Shaw EG, Simpson JR, Wharam Jr MD, Leibel S.  American College of Radiology ACR Appropriateness Criteria ™ 2000: Pre-Irradiation Evaluation and Management of Brain Metastases.  Radiology 2000; 215 (suppl): 1105-1110.

51.       Loeffler JS, Bloomer WD, Buckley JA, Gutin PH, Malcolm AW, Schupak KD, Larson D, Gaspar LE, Gibbs FA, Lewin AA, Mendenhall WM, Schneider JF, Shaw EG, Simpson JR, Wharam Jr MD, Rogers L, Leibel S. American College of Radiology ACR Appropriateness Criteria ™: Solitary Brain Metastasis.  Radiology 2000; 215 (suppl): 1111-1120.

52.       Shaw EG, Gaspar LE, Gibbs FA, Lewin AA, Wharam Jr MD, Larson D, Bloomer WD, Buckley JA,  Loeffler JS, Malcolm AW, Mendenhall WM, Schneider JF, Schupak KD, Simpson JR, Gutin PH, Rogers L, Leibel S.  American College of Radiology ACR Appropriateness Criteria ™ 2000: Multiple Brain Metastases.  Radiology 2000; 215 (suppl): 1121-1118.

53.       Vinas FC, Zamorano L, Gaspar LE, Matter A, Shamsa F.  Permanent 125I interstitial radiation therapy in the treatment of non-GBM high-grade gliomas.  Journal of Radiosurgery 2000; 3 (2): 91-98.

54.       Zamorano L, Vinas FC, Chuba P, Matter A, Gaspar LE, Portillo G, Shamsa F, Diaz FG.  Permanent Iodine-125 implants in the treatment of low-grade gliomas. Journal of Radiosurgery 2000; 3 (3): 147-154.

55.       Simpson JR, Medenhall WM, Scupak KD, Larson D, Bloomer WD, Buckley JA, Gaspar LE, Gibbs FA, Lewin AA, Loeffler JS, Malcom AW, Schneider JF, Shaw EG, Wharam Jr MD, Gutin PH, Rogers L, Leibel S.  American College of Radiology ACR Appropriateness Criteria ™ 2000: Follow-up and retreatment of brain metastasis.  Radiology 2000; 215 (suppl): 1129-1135.

56.       Gaspar LE, Scott C, Murray K, Curran W.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Rad Oncol Biol Phys 2000; 47 (4): 1001-1006.

57.       Ezzell, GA, Gaspar LE. Application of a genetic algorithm to optimizing radiation therapy treatment plans for pancreatic carcinoma. Med Dosim 2000; 25 (2): 93-97.

58.       Michalski J, Purdy JA, Gaspar L, Souhami L, Ballow M, Bradley J, Chao CK, Crane C, Eisbruch A, Fallowil D, Forster K, Fowler J, Gillin MT, Graham ML, Harms WB, Huq MS, Kline RW, Mackie TR, Mukherji S, Podogorsak EB, Roach M, Ryu J, Sandler H, Schultz CJ, Schell M, Verhey LJ, Vicini F, Winter KA.  Radiation Therapy Oncology Group.  Research Plan 2002-2006.  Image-Guided Radiation Therapy Committee.  Int J Radiat Oncol Biol Phys 2001; 51 (3 Suppl 2): 60-65.

59.       Willett C, Ajani J, Kelsen D, Sigurdson E, Abrams R, Berkley B, Benetz M, Crane C, Gaspar, L, Goodyear MD, Gunderson L, Haddock M, Hoffmann J, Janjan N, John M, Kachnic L, Krieg R, Landry J, Meropol N, Minsky B, Michell E, Mohiuddin M, Moulder J, Myerson R, Noyes D, Pajak TF, Raben D, Regine W, Rich T, Robertson JM, Russell A, Skibber J, Kim P.  Radiation Therapy Group.  Research Plan 2002-2006.  Gastrintestinal Cancer Committee.  Int J Radiat Oncol Biol Phys 2001; 51(3) Suppl 2: 19-27.

60.       Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, Desilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, Lee WR, Michalski J, Mydlo J, Pisansky T, Pollack A, Porterfield H, Rifkin M, Roach M, Sanda M, true L, Vijayakumar S, Winter KA, Zeitman A.  Radiation Therapy Oncology Group. Research Plan 2002-2006.  Genitourinary Cancer Committee.  Int J Radiat Oncol Biol Phys 2001; 51(3) Suppl 2: 28-38.

61.       Byhardt R, Komaki R, Ettinger D, Johnstone D, Bradley J, Franko A, Gaspar L, Gillin M, Langer C, Layne E, Movsas B, Munden R, Sause W, Stern J, Hsu J, Hartsell W, Yesner R.  Radiation Therapy Pncology Group.  Research Plan 2002-2006.  Lung Cancer Committee.  Int J Radiat Oncol Biol Phys 2001; 51 (3 Suppl 2): 44-52.

62.       Gaspar LE.  Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer.  Current opinion in oncology, Mar 2001: 13 (2): 110 – 115.

63.       Endicott TJ, Fisher BJ, Wong E, Paterson NAM, Gaspar LE, Bauman M.  Pulonary sequelae after electron spinal irradiation.  Radiotherapy and Oncology 2001; 60: 267-272.

64.       Gaspar LE, Winter K, Kocha WI, Pinover WH, Herskovic A, Graham M, Gunderson L.  Swallowing function and weight change observation in a Phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).  Cancer J. 2001 Sep-Oct; 7(5): 388-394.

65.       Goldberg Z, Gaspar LE, Lara P, Roberts P, Gandara D.  Combined modality treatment of non-small-cell lung cancer.  Lung Cancer Update 2001, Vol 1 (2): 1-11.

66.       Videtic GMM, Gaspar LE, Zamorano L, Stitt LW, Fontanesi J, Levin KJ.  Implant volume as a prognosis variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG Recursive Partitioning Analysis.  Implant Volume and Gliomas.  Int J Radiat Oncol Biol Phys 2001 Nov 15; 51(4): 963-968.

67.       Schefter TE, Gaspar LE.  Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): Is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus? Int J Radiat Oncol Biol Phys 2002 Feb 1; 52(2): 581-582 (Letter to the Editor).

68.       Kavanagh BD, Timmerman RD, Benedict SH, Wu Q, Schefter TE, Stuhr K, McCourt S, Newman F, Cardinale RM, Gaspar LE.  How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery:  Equivalent uniform dose or tumor control probability? Med Phys, 2003 Mar 30(3): 321-324.

69.       Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara Jr PN, Burris H, Gumerlock P, Crowley J, Livingston R.  Consolidation Docetaxel following concurrent chemoradiotherapy in pathologic stage IIIB non-small cell lung cancer: SWOG 9504.  J Clin Oncol, 2003 May 15; 21(10): 2004-2010.

70.       Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Pearlman A, Murray K, Gaspar L, Mehta M, Curran W, Gerber M.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.  J Clin Oncol 2003, 21(12):2364-71.

71.       Okunieff P, Meyn RE, Teicher BA, Thomas Jr CR, Gaspar LE, Raben D, Giri S, Lavey RS, Turrisi III AT, Swanson GP, Smalley SR.  Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003.  Am J Clin Oncol, 2003 Oct, 26(5): 522-529.

72.       Zamorano L, Li Q, Tekyi-Mensah S, Gaspar L, Fontanesi J, Levin K.  Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas. Stereotact Funct Neurosurg, 2003; 81(1-4):10-7.

73.       Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF.  Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and Motexafin Gadolinium (MGd): Result of a randomized phase III trial.  J Clin Oncol, 2004 Jan 1, 22(1): 157-165.

74.       Edelman MJ, Chansky K, Gaspar LE, Leigh B, Weiss GR, Taylor SA, Crowley J, Livingston R, Gandara DR.  Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.  J Clin Oncol. 2004 Jan 1; 22(1):127-32.

75.       Thomas CR Jr, Berkley BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL.  Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trails.  Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1405-10.

76.       Gaspar LE. Brain Metastases in Lung Cancer: Expert Opinion.  Expert review of anticancer therapy. Expert Rev. Anticancer Ther 2004;4(2):89-100.

77.       Andrews DW, Scott C, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran Jr WJ.  Phase III randomized trial comparing whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Results of the RTOG 9508 trial. Lancet. 2004 May 22;363(9422):1665-72.

78.       Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF.  Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and Motexafin Gadolinium: Results of a randomized phase III trial.  J Clin Oncol, 22(1): 157-165, 2004.

79.       Le Q, McCoy J, Williamson S, Ryu J, Gaspar LE, Edelman MJ, Dakhil SR, Sides SD, Crowley JJ, Gandara DR.  Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): A Southwest Oncology Group study.  Clinical Cancer Research Vol. 10: 5418-5424, 2004.

80.       Lillehei KO, Simon J, Gaspar, LE, Damek DM.  Non-small-cell lung cancer with brain metastasis.  Oncology (Huntington) 18 (14): 1725-1728, 2004.

81.       Turrisi AT, Crowley J, Albain K, Gaspar L, Gandara D.  Southwest Oncology Group: two decades of experience in non-small cell lung cancer. Semin Oncol. 2005 Apr;32(2 Suppl 3):S119-21. Review.

82.       Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ, Livingston RB, Gandara DR. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol. 2005 May 1;23(13):2955-61.

83.       Gaspar LE, Gay EG, Crawford J, Putnam JB, Herbst RS, Bonner JA.  Limited-stage small-cell lung cancer (Stage I-III): Observations from the National Cancer Data Base.  Clin Lung Cancer. 2005 May 6(6): 355-360.

84.       Kelsey CR, Schefter T, Nash SR, Russ P, Baron AE, Zeng C, Gaspar LE.  Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma. Am J Clin Oncol. 2005 Dec 28 (6): 576-580.

85.       Little AG, Rusch VW, Bonner JA, Gaspar LE, Green MR, Web WR, Stewart AK.  Patterns of surgical care of lung cancer patients.  Ann Thorac Surg, 2005 80:2051-2056.

86.       Schefter TE, Kavanagh BD, Timmerman, RD, Cardenes H, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1371-8.

87.       Gandara DR, Vallieres E, Gaspar LE, Kelly K, Albain KS, Herbst RS Jr, Lara PN Jr, Mack P, Gumerlock PH, Crowley JJ.  Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S93-7.

88.       Dillehay GL, Ellerbroek NA, Balon H, Brill DR, Grigsby PW, Macklis RM, Mauch PM, Mian TA, Potters L, Silberstein EB, Williams TR, Wong JC, Gaspar LE.  Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.  Int J Radiat Oncol Biol Phys. 2006 Apr 1; 64(5): 1299-1307.

89.       Schefter TE, Kavanagh BD, Raben D, Kane M, Chen C, Stuhr K, Kelly K, Michell JD, Bunn PA, Gaspar LE.  A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity. Int J Radiat Oncol Biol Phys. 2006;66(4), Supplement: S120-S127.

90.       Gandara DR, Chansky K, Albain KS, Gaspar LE, Lara PN Jr, Crowley J, Livingston R.  Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).  Clin Lung Cancer. 2006 Sep; 8(2): 116-121.

91.       Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE.  Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.  Acta Oncol. 2006; 45(7): 848-855.

92.       Ding M, Newman F, Kavanagh BD, Stuhr K, Johnson TK, Gaspar LE. Comparative dosimetric study of three-dementional conformal, dynamic conformal arc, and intensity-modulated radiotherapy for brain tumor treatment using Novalis system.  Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4 Suppl): S82 –S86.

93.       Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR; SWOG S9712.  Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712. J Clin Oncol. 2006 Nov 20;24(33):5242-6.

94.       Schwer AL, Gaspar LE.  Update in the treatment of brain metastases from lung cancer. Clin Lung Cancer. 2006 (3):180-186.

95.       Little AG, Gay EG, Gaspar LE, Stewart AK.  National survey of non-small cell lung cancer in the United States: Epidemiology, pathology and patterns of care. Lung Cancer 2007, 57: 253-260.

96.       Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA.  Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non Small-Cell Lung Cancer Guideline. J Clin Oncol. 2007 Dec 1;25(34):5506-18.                               

97.       Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG Database.  Int J Radiat Oncol Biol Phys, 70(2), Feb 2008; 510-514.

98.       Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C.  A Phase I Dose-Escalation Study of Fractionated Stereotactic Radiosurgery in Combination with Gefitinib in Patients with Recurrent Malignant Gliomas. Int J Radiat Oncol Biol Phys. 2008, 70(4):993-1001.

99.       Ding M, Newman F, Gaspar LE, Kavanagh BD, Stuhr K, Raben D, Li JS, Ma C-M.  4D Treatment planning tool for evaluation of motion effect of lung cancer treatment.  J. Physics. Conference Series 102 (2008); 1-6.

100.     Einhorn LH, Bonomi P, Bunn PA Jr, Camidge DR, Carbone DP, Choy H, Dubinett SM, Gandara DR, Gaspar LE, Govindan R, Johnson DH, Minna JD, Scagliotti G, West HJ, Herbst R.  Summary report 7th annual targeted therapies of the treatment of lung cancer.  J Thorac Oncol, 2008 May; 3(5): 545-555.

101.     Kelly K, Chansky K, Gaspar LE, Albain KS, Jett J, Ung YC, Lau DH, Crowley JJ, Gandara DR.  Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG 0023.  J Clin Oncol. 2008 May 20; 26(15):2450-2456.

102.     Gaspar LE, Ding M.  A review of intensity-modulated radiation therapy.  Curr Oncol Rep. 2008 Jul;10(4):294-9.

103.     Price KA, Azzoli CG, Gaspar LE.  Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.  Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):204-9.

104.     Wakelee H, Kernstine K, Vokes E, Schiller J, Baas P, Saijo N, Adjei A, Goss G, Gaspar L, Gandara DR, Choy H, Putnam JB.  Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer.  Clin Lung Cancer. 2008 Nov;9(6):346-51.

105.     Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W.  In reply to drs. Nieder and molls.  Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1619.

106.     Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT).  Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):9-14.

107.     Liu AK, Bagrosky B, Fenton LZ, Gaspar LE, Handler MH, McNatt SA, Foreman NK.  Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy.  Pediatr Blood Cancer. 2009 Feb;52(2):227-30.

108.     McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B.  Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.  Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):112-8.

109.     Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri S, Feigenberg S, Pugh TJ, Kane M, Gaspar L, Schefter TE.  Mature results of a multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.   J Clin Oncol, 2009 Apr 1; 27(10):1572-78.

110.     Rusthoven KE, Kavanagh BD, Burri SH, Chen, C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.  J Clin Oncol. 2009 Apr 1; 27(10): 1579-84.

111.     Ding M, Newman F, Chen C, Stuhr K, Gaspar LE.  Dosimetric comparison between 3D-CRT and IMRT using different multileaf collimators in the treatment of brain tumors.  Medical Dosimetry.  Medical Dosimetry, 2009 Jan 34(1):1-8.

112.     Olsen CC, Welsh J, Kavanagh BD, Franklin W, McCarter M, Cardenes HR, Gaspar LE, Schefter TE.  Microscopic and Macroscopic Tumor and Parenchymal Effects of Liver Stereotactic Body Radiotherapy.  Int J Radiat Oncol Biol Phys. 2009 Apr 1; 73(5):1414-24.

113.     Schwer AL, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C.  Radiographic and Histopathologic Observations after Combined EGFR Inhibition and Hypofractionated Stereotactic Radiosurgery in Patients with Recurrent Malignant Gliomas.  Int J Radiat Oncol Biol Phys. 2009 Apr 1; 73(5):1352-7.

114.     Liu AK, Foreman NI, Gaspar LE, Trinidad E, Handler MH.  Maximally Safe Resection Followed by Hypofractionated Re-Irradiation for Locally Recurrent Ependymoma in Children.  Pediatr Blood Cancer.  2009 July; 52(7):804-7.

115.     Le QT, Moon J, Redman M, Williamson SK, Lara PN Jr, Goldberg Z, Gaspar LE, Crowley JJ, Moore DF Jr, Gandara DR. Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222. Stanford University, Stanford, CA.  J Clin Oncol. 2009 Jun 20;27(18):3014-9.

116.     Camidge R, Gaspar LE, Goss G, Kelly K, Ramalingam S, Reckamp K, Simon G, Tsap M, West HJ, Herbst R, Johnson D, Bunn P, Govindan R. Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium. J Thorac Oncol. 2009 Jul;4(7):930-5.

117.     Okunieff P, Kachnic LA, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL, Philip PA, Raben D, Smalley SR, Swanson GP, Teicher BA, Thomas C, Vikram B, Zelefsky MJ, Baker LH.  Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.  Clin Cancer Res. 2009 Sept 15:15(18):5663-70.

118.     Videtic GM, Gaspar LE, Germano IM, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Suh JH, Wolfson AH, Wippold FJ. American College of Radiology Appropriateness Criteria on Multiple Brain Metastases. 2nd Int J Radiat Oncol Biol Phys. 2009 Nov 15:75(4).961-5.

119.     Sangha R, Lara PN Jr, Adjei AA, Baas P, Choy H, Gaspar LE, Goss G, Saijo N, Schiller JH, Vokes EE, Gandara DR. Cooperative Group Research Endeavors in Small-Cell Lung Cancer: Current and Future Directions. Clin Lung Cancer. 2009 Sep, 10(5):322-30.

120.     Sperduto P, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M. Diagnosis-Specific Prognostic Factors, Indices and Treatment Outcomes for Patients with Newly-Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4259 Patients. Int J Radiat Oncol Biol Phys. 2009 Nov 24.

121.     Mehta MP, Paleologos NA, Mikkelsen T, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, McDermott M, Olsen JJ, Patchell RA, Ryken TC, Kalkanis SN. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2009 Dec 4

122.     Olsen JJ, Paleologos NA, Gaspar LE, Robinson PD, Morris RE, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Kondziolka D, Linksey ME, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Patchell RA, Ryken TC, Kalkanis SN. The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. J Neurooncol. 2009 Dec 3.

123.     Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelesen T, Olsen JJ, Paleologos NA, Patchell RA, Ryken TC, Linksey ME. The role of surgical resection in the management of newly diagnosed brain metastases: s systematic review and evidence-based clinical practice guideline. J Neurooncol. 2009 Dec 4.

124.     Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, Morris RE, Ammirati M, Andrews DW, Asher AL, Cobbs CS, Kondziolka D, Linksey ME, Loeffler JS, McDermott M, Mikkelsen T, Olsen JJ, Paleologos NA, Ryken TC, Kalkanis SN. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2009 Dec 4.

  

TEXTBOOK CONTRIBUTIONS, INVITED PAPERS AND EDITORIALS:

 

1.         Gaspar LE.  Guest Editor, Oncore: Lung Cancer; January, 1991.

2.         Gaspar LE, Cairncross JG.  Hyperthermia and brachytherapy for glioma - Will cooler heads prevail?  Int J Rad Oncol Biol Phys, 24:803-804, 1992.

3.         Anscher MS, Gaspar LE, Swift PS, Marks LB.  Radiation injury of the pituitary hypothalamic axis and intellectual defects.  Neurosurgery (2nd Edition) Chapter 189, 1993.

4.         Poplin E, Gaspar LE, Nigro N, Sheahan D.  Anal canal.  Clinical Oncology, Abeloff, Armitage, Lichter, and Niederhuber (eds), Chuchill Livingstone, 62:1287-1303, 1995.

5.         Gaspar LE.  Radiosurgery for AVMS: Evaluating the risks and benefits.  J Neurosurg 83:381, 1995.  (Letter)

6.         Gaspar LE, Nag S.  Esophageal brachytherapy.  Principles and practices of brachytherapy, Nag (ed), Futura Publishing Co., 15:305-321, 1997.

7.         Zamorano L, Gaspar LE.  Low dose-rate brachytherapy in the treatment of malignant gliomas.  Textbook of stereotactic and functional neurosurgery, Gildenberg and Tasker (eds), McGraw-Hill, Inc., Chapter 71, 1997.

8.         Gaspar LE. Esophageal brachytherapy: A phantom menace? Int J Rad Oncol Biol Phys, 25 (3): 549-550, 1999.

9.         Gaspar LE.  Intraluminal brachytherapy for malignant endobronchial tumors: An update on low-dose rate versus high-dose rate radiation therapy.  Clinical Lung Cancer; Aug 2001: 69.

10.       Gaspar LE.  Advances in the treatment of stage III non-small-cell lung cancer: Southwest Oncology Group trials.  Cancer Conference Highlights 2002, Vol 6 (11): 3-5.

11.       Gaspar LE.  Prophylactic cranial irradiation for locally advanced non-small cell lung cancer.  Oncology, 17(6): 784.

12.       Gaspar LE, Mertens W, Raben, D, Evans S.  Clinical aspects and management of anal cancer.  Gastrointestinal Oncology, Oxford University Press; Chapter 63: 760-769, 2004.

13.       Chen C, Gaspar LE.  Brain metastases from small cell lung cancer: The Quan/Videtic/Suh Article Reviewed.  Oncology 18(8); 980, 2004.

14.       Gaspar LE, Rogers LR.  Prophylactic cranial irradiation for small cell lung cancer – To Do or Not To Do?  J Support Oncol 2004:2:133-135. 

15.       Lillehei KO, Simon J, Gaspar LE, Damek DM.  Non-small-cell lung cancer with brain metastasis. Oncology, 18(14) Second Opinion, 2004; 1725-1728.

16.       Gaspar LE, Schefter T.  Noninvasive therapy for early lung cancer.  Ed F Hirsch, P Bunn, H Kato, J Mulshine, 2006, Chapter 17: 289-316.

17.       Chuba P, Zamorano L, Gaspar LEBrachytherapy for brain tumors. Ed S Nag. (In press)

18.       Gaspar LE.  Stereotactic body radiation therapy for lung tumors: System-related issues and complications.  Clinical Lung Cancer, 2007 Vol 8(4): p 233.

19.       Gaspar LE. Palliative irradiation of visceral metastases.  5th Edition Principals and Practice of Radiation Oncology.  Lippincott, 2007.

20.       Pugh TJ, Gaspar LE.  Prophylactic cranial irradiation for patients with lung cancer.  Clinical Lung Cancer, 2007;8 (6): 365-368.

21.       Gaspar LE. Stereotactic body radiation therapy for lung tumors: System-related issues and complications. Clin Lung Cancer. 2007 Jan;8(4):233.

22.       Gaspar LE.  Patient demographics in HOG LUN 01-24 versus SWOG 9504: apples versus oranges?  Clin Lung Cancer. 2007 Sep;8(8):466-7.

23.       Gaspar LE, Ding M.  A review of intensity-modulated radiation therapy for lung cancer.  Current Oncology Reports, 2008 Jul, 10(4): 294-299.

24.       Kono SA, Weyant M, Franklin W, Gaspar LE, Camidge DR.  Surprised by Stage III:  Unexpected N2 Lymph Node Involvement Found During Surgery for Early-Stage NSCLC.  Oncology  2009 Apr 30; 23(5):424-9.

25.       Pugh TJ, Gaspar LE. Stage III Non-Small Cell Lung Cancer and Brain Metastases: The role of radiation therapy. European Journal of Clinical and Medical Oncology. (In Press)